lördag 3 april 2021

https://www.gatesfoundation.org/



BILL GATES HAR KØBT DANSKE FORSKERE FOR 160 MILLIONER KRONER

Bill Gates & Co. har investeret for over 160 millioner kroner i forskere og videninstitutioner i Danmark.

Det viser en søgning på How We Work-siden på Bill & Melinda Gates Foundations egen hjemmeside udført i dag.

160 millioner kroner er et betragteligt beløb, der burde kunne købe en hel del respekt og goodwill – jeg tør ikke bruge ordet bestikkelse – blandt pengehungrende virus-, vaccine- og medicinforskere m.v. i Danmark. Nu er det så tilsyneladende blevet tid til den store return on investment.

Her er opgørelsen af donationer fra Bill & Melinda Gates Foundation til forskellige institutioner i Danmark fra 2005 til 2019:

  • Statens Serum Institut, 1. juli 2005: $14.889.455
  • Københavns Universitet, 1. november 2008: $100.000
  • Københavns Universitet, 18. november 2009: $3.484.384
  • Københavns Universitet, 1, november 2010: $100.000
  • Statens Serum Institut, 14. november 2011: $326.293
  • Statens Serum Institut, 2. oktober 2012: $158.739
  • Aarhus, 9. oktober 2012: $135.000
  • Københavns Universitet, 10. oktober 2012: $813.050
  • Statens Serum Institut, 15. november 2012: $551.049
  • Syddansk Universitet, 15. januar 2015: $270.147
  • Statens Serum Institut, 15. april 2015: $100.000
  • Aarhus, 20. december 2015: $85.000
  • Københavns Universitet, 28. september 2017: $758.122
  • DTU, 25. november 2018: $1.084.000
  • Statens Serum Institut, 3. december 2019: $207.877
  • Maternity Foundation, 19. september 2019: $1.900.100
  • Lægemiddelstyrelsen, 10. oktober 2019: $600.000

Den samlede investeringssum er $25.563.216, som svarer til DKK 160.676.571 efter dagens valuta.

En oplagt konsekvens af den store investering i danske forskere kan være, at ingen af dem ønsker at gå imod det herskende narrativ om corona nu, da de ved, at det herskende narrativ er støttet eller måske ligefrem skabt af Bill Gates & Co., og da de danske forskere så formentlig kan se frem til ikke at modtage donationer i fremtiden, hvis de går imod den store pengemagt.

Penge er magt – også indenfor videnskab og forskning. Hele det moderne forskningssystem er baseret på, at hver enkelt forsker nærmest er en selvstændig virksomhed, der konstant er på udkig efter nye pengekasser, som man kan stikke snabelen ned i. Det er kun muligt at forske og tænke frit, hvis man træder ud af det system. Man kan kalde det korrupt, men den enkelte forsker gør sådan set bare, hvad systemet kræver af dem: skaf penge! Underforstået: lad pengene bestemme over din forskning!

Det er veldokumenteret, at sponsorens økonomiske interesser påvirker forskningens resultater og fortolkning. Det kan ske helt automatisk, uden at forskeren selv er bevidste om, at de farver deres forsøgsdesign, databehandling, resultatdiskussion og konklusion, så sponsoren bliver glad. Det betyder, at man skal se sig godt for, hvis man vil finde uafhængig forskning, der udelukkende er interesseret i at fremme menneskers sundhed. Det er trist, men sådan er det.

https://perbraendgaard.dk/2020/09/18/bill-gates-har-koebt-danske-forskere-for-160-millioner-kroner/







Your search for Karolinska  returned 17 results.


AUGUST 29, 2018

Karolinska Institutet

Purpose: to generate strong protection against infectious diseases for which no vaccines are yet available, or existing vaccines are suboptimal


APRIL 15, 2015

Karolinska Institutet

Purpose: to test a portable, bio-aerosol sampler for mycobacteria would enable the formal characterization of the transmissible form of M. tuberculosis and open for the development and deployment...


OCTOBER 31, 2017

Karolinska Institutet

Purpose: to increase access to high quality FP services and commodities in Nigeria


FEBRUARY 11, 2020

Karolinska Institutet

Purpose: to generate strong protection against infectious diseases for which no vaccines are yet available, or existing vaccines are sub-optimal



AUGUST 28, 2020

Karolinska Institutet

Purpose: to understand disease severity and identify correlates of protection in human Sars-CoV-2 infection/Covid-19


MAY 1, 2010

Karolinska Institutet

Purpose: to test the theory that chronic parasitic worm infections not only increase susceptibility to certain infections, but also impair the ability of the immune system to respond effectively...


JULY 9, 2015

Karolinska Institutet

Purpose: to test the hypothesis that it is both safe and beneficial to extend current indications for skin-to-skin contact to unstable, at-risk low birth weight neonates from birth


SEPTEMBER 29, 2020

Karolinska Institutet

Purpose: to determine long-term immunogenicity and protective efficacy of a leading CoV2 vaccine produced in insect cells, co-administered with either a saponin-based adjuvant (Matrix M)


OCTOBER 10, 2011

Karolinska University Hospital

Purpose: to develop a vaccination delivery model that employs an application tool on cell phones and a clinical decision support system to coordinate vaccination programs in rural communities...


APRIL 19, 2011

Karolinska Institutet

Purpose: to develop a test which measures the concentration of lactate in the amniotic fluid of laboring women to help obstetricians and midwifes predict labor outcomes.


NOVEMBER 5, 2015

Karolinska Institutet

Purpose: to develop on-line learning for model based drug development skills and hands on training and development of skills needed to analyze data from drug evaluations, clinical drug development...


OCTOBER 22, 2019

Karolinska Institutet

Purpose: To execute a step by step comprehensive program to determine the feasibility of establishing Centers of Excellence in evidence-based care in Maternal, Newborn and Child health and nutrition...




JUNE 21, 2013

Scientific Advisory Committee

Our Global Health Program advisory committee comprises a group of esteemed experts from outside of the foundation who offer a wide range of experiences and perspectives. This group...








Karolinska Institutet


July 2015
to test the hypothesis that it is both safe and beneficial to extend current indications for skin-to-skin contact to unstable, at-risk low birth weight neonates from birth
$429,279  = 4 milj Skr
11
Maternal, Neonatal and Child Health
Global Development
Stockholm
https://ki.se/en/startpage


Karolinska Institutet


April 2011
to develop a test which measures the concentration of lactate in the amniotic fluid of laboring women to help obstetricians and midwifes predict labor outcomes.
$100,000
19
Discovery and Translational Sciences
Global Health
Stockholm
https://ki.se/en/startpage


Karolinska Institutet


October 2019
To execute a step by step comprehensive program to determine the feasibility of establishing Centers of Excellence in evidence-based care in Maternal, Newborn and Child health and nutrition in Sub-Saharan Africa
$418,257
14
Global Health and Development Public Awareness and Analysis, Maternal, Neonatal and Child Health, Nutrition
Global Development
Stockholm
https://ki.se/en/startpage